NASDAQ:ABUS
Arbutus Biopharma Corporation Stock Insider Trading
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 92.198.
In total, the insiders bought 34 426 422 and sold 1 535 268 ABUS shares in the last 100 trades.
| Date | Action | Amount | Person | Type |
| May 24, 2023 | Buy | 55 000 | Henriques Richard C Jr | Stock Option (Right to Buy) |
| May 24, 2023 | Buy | 55 000 | Burgess Daniel D | Stock Option (Right to Buy) |
| May 24, 2023 | Buy | 55 000 | Manchester Keith S | Stock Option (Right to Buy) |
| May 24, 2023 | Buy | 55 000 | Torti Frank | Stock Option (Right to Buy) |
| May 24, 2023 | Buy | 55 000 | Meyers James R | Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 83 700 | Mcelhaugh Michael J. | Common Shares |
| Feb 01, 2023 | Buy | 334 700 | Mcelhaugh Michael J. | Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 82 200 | Sofia Michael J. | Common Shares |
| Feb 01, 2023 | Buy | 328 700 | Sofia Michael J. | Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 79 000 | Hastings David C | Common Shares |
| Feb 01, 2023 | Buy | 316 000 | Hastings David C | Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 216 500 | Collier William H. | Common Shares |
| Feb 01, 2023 | Buy | 866 000 | Collier William H. | Stock Option (Right to Buy) |
| Feb 01, 2023 | Buy | 69 700 | Howard Elizabeth | Common Shares |
| Feb 01, 2023 | Buy | 278 700 | Howard Elizabeth | Stock Option (Right to Buy) |
| May 25, 2022 | Buy | 41 000 | Henriques Richard C Jr | Stock Option (Right to Buy) |
| May 25, 2022 | Buy | 41 000 | Burgess Daniel D | Stock Option (Right to Buy) |
| May 25, 2022 | Buy | 41 000 | Meyers James R | Stock Option (Right to Buy) |
| May 25, 2022 | Buy | 41 000 | Torti Frank | Stock Option (Right to Buy) |
| May 25, 2022 | Buy | 41 000 | Tran Tram | Stock Option (Right to Buy) |
| May 25, 2022 | Buy | 41 000 | Manchester Keith S | Stock Option (Right to Buy) |
| Jan 20, 2022 | Buy | 787 550 | Collier William H. | Stock Option (Right to Buy) |
| Jan 20, 2022 | Buy | 285 000 | Hastings David C | Stock Option (Right to Buy) |
| Jan 20, 2022 | Buy | 237 500 | Howard Elizabeth | Stock Option (Right to Buy) |
| Jan 20, 2022 | Buy | 285 000 | Sofia Michael J. | Stock Option (Right to Buy) |
| Jan 20, 2022 | Buy | 256 500 | Picchio Gaston | Stock Option (Right to Buy) |
| Jan 20, 2022 | Buy | 325 850 | Mcelhaugh Michael J. | Stock Option (Right to Buy) |
| Dec 01, 2021 | Sell | 200 000 | Sofia Michael J. | Common Shares |
| Nov 09, 2021 | Buy | 44 000 | Tran Tram | Stock Option (Right to Buy) |
| Nov 09, 2021 | Buy | 0 | Tran Tram | |
| Oct 18, 2021 | Buy | 22 833 922 | Roivant Sciences Ltd. | Common shares, without par value |
| Oct 18, 2021 | Sell | 1 164 000 | Roivant Sciences Ltd. | Series A participating convertible preferred shares |
| Jun 03, 2021 | Buy | 22 000 | Burgess Daniel D | Stock Options |
| Jun 03, 2021 | Buy | 22 000 | Henriques Richard C Jr | Stock Options |
| Jun 03, 2021 | Buy | 22 000 | Meyers James R | Stock Options |
| Jun 03, 2021 | Buy | 22 000 | Manchester Keith S | Stock Options |
| Jun 03, 2021 | Buy | 22 000 | Cheng Andrew | Stock Options |
| Jun 03, 2021 | Buy | 22 000 | Torti Frank | Stock Options |
| Feb 13, 2021 | Buy | 250 000 | Picchio Gaston | Stock Options |
| Feb 13, 2021 | Buy | 250 000 | Hastings David C | Stock Options |
| Feb 13, 2021 | Buy | 675 000 | Collier William H. | Stock Options |
| Feb 13, 2021 | Buy | 200 000 | Howard Elizabeth | Stock Options |
| Feb 13, 2021 | Buy | 249 000 | Mcelhaugh Michael J. | Stock Options |
| Feb 13, 2021 | Buy | 290 000 | Sofia Michael J. | Stock Options |
| Feb 09, 2021 | Sell | 20 000 | Mcelhaugh Michael J. | Common Stock |
| Dec 14, 2020 | Sell | 30 000 | Mcelhaugh Michael J. | Common Stock |
| Dec 14, 2020 | Sell | 10 000 | Mcelhaugh Michael J. | Common Stock |
| Sep 23, 2020 | Buy | 50 000 | Picchio Gaston | Common Stock |
| Sep 23, 2020 | Buy | 70 000 | Collier William H. | Stock Options |
| Jul 23, 2020 | Sell | 20 000 | Mcelhaugh Michael J. | Common Stock |
| May 28, 2020 | Buy | 22 000 | Meyers James R | Stock Options |
| May 28, 2020 | Buy | 22 000 | Henriques Richard C Jr | Stock Options |
| May 28, 2020 | Buy | 262 313 | Collier William H. | Stock Options |
| May 28, 2020 | Buy | 22 000 | Torti Frank | Stock Options |
| May 28, 2020 | Buy | 22 000 | Cheng Andrew | Stock Options |
| May 28, 2020 | Buy | 22 000 | Manchester Keith S | Stock Options |
| May 28, 2020 | Buy | 22 000 | Burgess Daniel D | Stock Options |
| Feb 17, 2020 | Buy | 79 500 | Howard Elizabeth | Stock Options |
| Feb 17, 2020 | Buy | 250 000 | Sofia Michael J. | Stock Options |
| Feb 17, 2020 | Buy | 150 000 | Picchio Gaston | Stock Options |
| Feb 17, 2020 | Buy | 367 087 | Collier William H. | Stock Options |
| Feb 17, 2020 | Buy | 100 000 | Hastings David C | Stock Options |
| Feb 17, 2020 | Buy | 200 000 | Mcelhaugh Michael J. | Stock Options |
| Feb 18, 2020 | Buy | 0 | Venker Eric | |
| Aug 17, 2019 | Buy | 60 000 | Cheng Andrew | Stock Options |
| Aug 17, 2019 | Buy | 22 000 | Potter Myrtle S | Stock Options |
| Aug 17, 2019 | Buy | 0 | Cheng Andrew | |
| Aug 17, 2019 | Buy | 22 000 | Burgess Daniel D | Stock Options |
| Aug 17, 2019 | Buy | 22 000 | Meyers James R | Stock Options |
| Aug 17, 2019 | Buy | 22 000 | Manchester Keith S | Stock Options |
| Aug 17, 2019 | Buy | 22 000 | Henriques Richard C Jr | Stock Options |
| Aug 17, 2019 | Buy | 22 000 | Torti Frank | Stock Options |
| Jul 10, 2019 | Buy | 0 | Lo Andrew | |
| Jul 10, 2019 | Buy | 0 | Machado Patrick | |
| Jul 10, 2019 | Buy | 0 | Viking Global Performance Llc | |
| Jul 10, 2019 | Buy | 0 | Viking Global Investors Lp | |
| Jul 10, 2019 | Buy | 0 | Svf Investments (uk) Ltd | |
| Jul 10, 2019 | Buy | 0 | Dexxon Holdings Ltd. | |
| Jul 10, 2019 | Buy | 0 | Qvt Associates Gp Llc | |
| Jun 24, 2019 | Buy | 1 112 000 | Collier William H. | Employee Stock Option (Right to Buy) |
| Jun 24, 2019 | Buy | 0 | Collier William H. | |
| Mar 01, 2019 | Buy | 137 500 | Picchio Gaston | Employee Stock Option (Right to Buy) |
| Mar 01, 2019 | Buy | 145 000 | Sofia Michael J. | Employee Stock Option (Right to Buy) |
| Mar 01, 2019 | Buy | 104 500 | Mcelhaugh Michael J. | Employee Stock Option (Right to Buy) |
| Mar 01, 2019 | Buy | 357 500 | Murray Mark J. | Employee Stock Option (Right to Buy) |
| Mar 01, 2019 | Buy | 137 500 | Howard Elizabeth | Employee Stock Option (Right to Buy) |
| Mar 01, 2019 | Buy | 137 500 | Hastings David C | Employee Stock Option (Right to Buy) |
| Jan 01, 2019 | Buy | 0 | Viking Global Equities Master Ltd. | Common Shares |
| Dec 11, 2018 | Sell | 0 | Mcelhaugh Michael J. | Common Shares |
| Dec 11, 2018 | Sell | 25 000 | Mcelhaugh Michael J. | Employee Stock Option (Right to Buy) |
| Dec 11, 2018 | Sell | 41 268 | Mcelhaugh Michael J. | Employee Stock Option (Right to Buy) |
| Dec 11, 2018 | Buy | 7 500 | Vandenenden Koert | Employee Stock Option (Right to Buy) |
| Nov 28, 2018 | Buy | 25 000 | Murray Mark J. | Common Shares |
| Nov 28, 2018 | Sell | 25 000 | Murray Mark J. | Employee Stock Option (Right to Buy) |
| Nov 26, 2018 | Buy | 44 000 | Torti Frank | Director Share Option (right to buy) |
| Nov 26, 2018 | Buy | 0 | Torti Frank | |
| Oct 18, 2018 | Buy | 44 000 | Potter Myrtle S | Director Share Option (Right to Buy) |
| Oct 18, 2018 | Buy | 0 | Potter Myrtle S | |
| Oct 18, 2018 | Buy | 44 000 | Meyers James R | Director Share Option (Right to Buy) |
| Oct 18, 2018 | Buy | 0 | Meyers James R |
About Arbutus Biopharma Corporation
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical trial targeted to hepatocytes that inhibits viral replication and reduces various HBV antigens using novel ... ABUS Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
